Selectra Investments J. Lamarck Biotech D (LU1246176264)
132.96
-0.61
(-0.46%)
EUR |
Oct 07 2026
LU1246176264 Net Asset Value
Net Asset Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Asset Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 132.96 |
| October 06, 2026 | 133.57 |
| October 05, 2026 | 135.40 |
| October 02, 2026 | 132.89 |
| October 01, 2026 | 133.82 |
| September 30, 2026 | 135.20 |
| September 29, 2026 | 135.84 |
| September 28, 2026 | 134.49 |
| September 25, 2026 | 134.18 |
| September 24, 2026 | 135.61 |
| September 23, 2026 | 136.05 |
| September 22, 2026 | 139.65 |
| September 21, 2026 | 136.30 |
| September 18, 2026 | 134.97 |
| September 17, 2026 | 136.21 |
| September 16, 2026 | 132.09 |
| September 15, 2026 | 132.19 |
| September 14, 2026 | 135.49 |
| September 11, 2026 | 133.86 |
| September 10, 2026 | 135.14 |
| September 09, 2026 | 136.82 |
| September 08, 2026 | 139.44 |
| September 07, 2026 | 143.52 |
| September 04, 2026 | 143.90 |
| September 03, 2026 | 144.54 |
| Date | Value |
|---|---|
| September 02, 2026 | 145.17 |
| September 01, 2026 | 142.85 |
| August 31, 2026 | 141.84 |
| August 28, 2026 | 142.48 |
| August 27, 2026 | 144.98 |
| August 26, 2026 | 144.98 |
| August 25, 2026 | 146.61 |
| August 24, 2026 | 142.03 |
| August 21, 2026 | 143.22 |
| August 20, 2026 | 140.26 |
| August 19, 2026 | 145.09 |
| August 18, 2026 | 139.09 |
| August 17, 2026 | 138.52 |
| August 14, 2026 | 137.23 |
| August 13, 2026 | 137.91 |
| August 12, 2026 | 139.15 |
| August 11, 2026 | 138.62 |
| August 10, 2026 | 138.95 |
| August 07, 2026 | 137.63 |
| August 06, 2026 | 135.05 |
| August 05, 2026 | 135.30 |
| August 04, 2026 | 135.77 |
| August 03, 2026 | 131.59 |
| July 31, 2026 | 130.44 |
| July 30, 2026 | 133.89 |
Net Asset Value (NAV) Definition
Net Asset Value measures the total value of a security based on assets divided by shares outstanding. This metric is calculated by (Total Assets - Total Liabilities) / Shares Outstanding.
Net Asset Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Asset Value Benchmarks
| MEDICAL BioHealth S | 660.99 |
| RH&P Global Life Sciences Fund I EUR Dis | 125.54 |
| Pharus SICAV - Medical Innovation B EUR Acc | 1338.63 |
| Allianz Biotechnologie - R - EUR | 198.85 |
| DWS ESG Biotech TFC | 201.81 |
Net Asset Value Excel Add-In Codes
| Metric Code: net_asset_value |
| Latest Data Point: =YCP("M:LU1246176264", "net_asset_value") |
| Last 5 Data Points: =YCS("M:LU1246176264", "net_asset_value", -4) |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |